Chronic myelomonocytic leukemia patients with RAS pathway mutations show high in vitro myeloid colony formation in the absence of exogenous growth factors

Leukemia. 2016 Nov;30(11):2280-2281. doi: 10.1038/leu.2016.235. Epub 2016 Aug 18.
No abstract available

Publication types

  • Letter

MeSH terms

  • Humans
  • In Vitro Techniques
  • Intercellular Signaling Peptides and Proteins / pharmacology
  • Leukemia, Myelomonocytic, Chronic / genetics*
  • Leukemia, Myelomonocytic, Chronic / pathology
  • Mutation*
  • Oncogene Protein p21(ras) / genetics*

Substances

  • Intercellular Signaling Peptides and Proteins
  • Oncogene Protein p21(ras)